Effect of high MMP2 and low MMP9 baseline serum levels on outcome in patients with HER2-positive inflammatory breast cancer (IBC) treated with bevacizumab (BEV)- and trastuzumab (TRA)-based neoadjuvant chemotherapy (NAC) in the BEVERLY 2 study

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. 600
Main Authors Tabouret, Emeline, Goncalves, Anthony, Bertucci, Francois, Pierga, Jean-Yves, Petit, Thierry, Levy, Christelle, Ferrero, Jean-Marc, Campone, Mario, Gligorov, Joseph, Lerebours, Florence, Roche, Henri Hubert, Bachelot, Thomas Denis, Toiron, Yves, Borg, Jean-Paul, Chinot, Olivier L., Viens, Patrice
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.600